IT

The 10th annual Global Corporate Venturing Symposium marked the first return to Europe of the main corporate, university and government venturing units alongside the rest of the venture capital and startup ecosystem. Its mission is: informing, connecting, and transforming the venture ecosystem.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.

Capital One Ventures and Snowflake Ventures backed the data analytics software developer in a round that more than doubled its valuation to $4.2bn.

NTT Docomo took part in a series A round for VR technology developer Hikky that stands at $57.1m so far while cancer therapy developer Ankyra raised $45m from investors including GV.

The corporate-backed fashion and beauty marketplace operator listed on the BSE and NSE in India and reached a market cap of $13.5bn.

Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.

Deep Nishar has departed from his SBIA senior managing partner role to help develop enterprise software, biotech and life sciences pipelines at the venture firm.

Microsoft and Axa both returned for the cybersecurity technology provider’s latest round, taking its overall funding to $272m.

Cybersecurity platform developer SafeBreach and home improvement technology provider Block Renovation each raised $50m or over in corporate-led rounds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Citi-backed customer engagement platform developer has set terms for an initial public offering which could top $400m.